Latest Capital Raises News

Sultan Resources has increased its capital raising to $1.1 million through additional investor interest, with key approvals pending at the upcoming AGM. The funds aim to accelerate exploration at its promising projects in Namibia and Western Australia.

EMVision Medical Devices has closed its $2 million Share Purchase Plan ahead of schedule due to strong investor demand, signaling robust market interest in its neurodiagnostic technology.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.

SIV Capital Limited reported a $110,000 net cash outflow for Q1 FY26, maintaining a strong cash reserve of $8.07 million despite its securities suspension by ASX since December 2024.

Austral Resources Australia has locked in $40 million through a discounted share placement, setting the stage for its ASX reinstatement and ambitious expansion in Queensland's copper belt.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy shares at a discount, following a recent A$130 million institutional placement and its acquisition of IMPECT GmbH.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 in shares at a discount, following a successful A$130 million institutional placement. The capital raise supports the recent acquisition of IMPECT GmbH and future strategic opportunities.

Manuka Resources has raised A$15 million to accelerate production at its Wonawinta Silver Mine and fund exploration drilling at Mt Boppy and Pipeline Ridge in New South Wales.

Latrobe Magnesium Limited has announced a fully underwritten $10 million equity raise through a $6 million placement and a $4 million rights issue to fund its magnesium production expansion. The capital will support the commissioning of its Demonstration Plant and advance plans for a 10,000 tonne commercial facility.

Solis Minerals has raised $5.9 million to fund the acquisition and exploration of its promising Cucho copper project, alongside ongoing and upcoming drilling programs at Ilo Este and Cinto in Peru.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Tasman Resources has raised $2 million through a two-tranche placement to fund a promising drilling campaign at Parkinson Dam and broaden its project portfolio, alongside appointing a new director to steer its strategic ambitions.